| Relevance | RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | Annotations | Match | Type | 1000 | 1331644 | AASTH7_H | Allergic/atopic asthma related QTL 7 (human) | 2.29 | Reversible airflow obstruction | asthma score | 12 | 74133886 | 133812422 | Human | n/a | region | qtl | 1000 | 1559248 | SAPOA1_H | Serum apolipoprotein A level QTL 1 (human) | 2.02 | Apolipoprotein level | apolipoprotein A-I | 12 | 95712415 | 133789251 | Human | n/a | region | qtl | 1000 | 1643452 | BW104_H | Body weight QTL 104 (human) | 1.89 | .005 | Body fat amount | abdominal visceral | 12 | 102789645 | 128789645 | Human | n/a | region | qtl | 1000 | 2292994 | PRSTS146_H | Prostate tumor susceptibility QTL 146 (human) | 5.69 | .000022 | Prostate tumor susceptibility | 12 | 103060538 | 129060538 | Human | n/a | region | qtl | 1000 | 1331642 | AASTH6_H | Allergic/atopic asthma related QTL 6 (human) | 2.46 | .0004 | Reversible airflow obstruction | post-bronchodilator FEV1 | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1357293 | AASTH20_H | Allergic/atopic asthma related QTL 20 (human) | 1.13 | Reversible airflow obstruction | post-bronchodilator FEV1 | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1643313 | BW234_H | Body weight QTL 234 (human) | 1.08 | Body weight | body mass index | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1643266 | BW201_H | Body weight QTL 201 (human) | 3.79 | .00001 | Body fat amount | percent body fat | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1643270 | BW198_H | Body weight QTL 198 (human) | 3.57 | .00003 | Body weight | BMI | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1643277 | BW203_H | Body weight QTL 203 (human) | 3.05 | .00009 | Body morphometry | waist circumference | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 2314720 | INSUL18_H | Insulin level QTL 18(human) | 2 | .106 | Insulin level | 12 | 103082760 | 129082760 | Human | n/a | region | qtl | 1000 | 1298449 | UAE2_H | Urinary albumin excretion QTL 2 (human) | 2 | .005 | Urinary albumin excretion | urine albumin:creatinine ratio (ACR) | 12 | 103232104 | 129232104 | Human | n/a | region | qtl | 1000 | 2289480 | SLEP16_H | Serum leptin level QTL 16 (human) | 2.06 | Hormone level | leptin | 12 | 106170388 | 132170388 | Human | n/a | region | qtl | 1000 | 2316666 | GLUCO252_H | Glucose level QTL 252 (human) | 3.65 | Glucose level | 12 | 107147609 | 133147609 | Human | n/a | region | qtl | 1000 | 1643308 | BW235_H | Body weight QTL 235 (human) | 1.86 | Body weight | body mass index | 12 | 107188584 | 133188584 | Human | n/a | region | qtl | 1000 | 1643411 | BW278_H | Body Weight QTL 278 (human) | 1.79 | .002 | Body weight | 12 | 107188584 | 133188584 | Human | n/a | region | qtl | 1000 | 2293466 | PRSTS305_H | Prostate tumor susceptibility QTL 305 (human) | .024 | Prostate tumor susceptibility | 12 | 107188584 | 133188584 | Human | n/a | region | qtl | 1000 | 1643468 | SLIPL18_H | Serum lipid level QTL 18 (human) | 2.6 | .02 | Lipid level | 12 | 114961269 | 133812422 | Human | n/a | region | qtl | 1000 | 2314558 | GLUCO46_H | Glucose level QTL 46 (human) | 1.1 | Glucose level | 12 | 114961269 | 133812422 | Human | n/a | region | qtl | 1000 | 2289606 | BW476_H | Body weight QTL 476 (human) | 2.9 | Body fat amount | abdominal | 12 | 116060455 | 131962898 | Human | n/a | region | qtl | 1000 | 2316044 | GLUCO197_H | Glucose level QTL 197 (human) | .03 | Glucose level | 12 | 116082709 | 126625403 | Human | n/a | region | qtl | 1000 | 1576332 | MYI14_H | Myocardial infarction susceptibility QTL 14 (human) | 4.44 | Myocardial infarction susceptibility | early-onset | 12 | 117397776 | 133812422 | Human | n/a | region | qtl | 1000 | 1576338 | MYI6_H | Myocardial infarction susceptibility QTL 6 (human) | 5.62 | Myocardial infarction susceptibility | early-onset | 12 | 117397776 | 133812422 | Human | n/a | region | qtl | 1000 | 2293420 | PRSTS217_H | Prostate tumor susceptibility QTL 217 (human) | 1.89 | Prostate tumor susceptibility | 12 | 117397776 | 133812422 | Human | n/a | region | qtl | 1000 | 2293368 | PRSTS218_H | Prostate tumor susceptibility QTL 218 (human) | 1.05 | Prostate tumor susceptibility | 12 | 117397776 | 133812422 | Human | n/a | region | qtl | 1000 | 2293401 | PRSTS216_H | Prostate tumor susceptibility QTL 216 (human) | 1.76 | Prostate tumor susceptibility | 12 | 117397776 | 133812422 | Human | n/a | region | qtl | 1000 | 2289471 | BW218_H | Body weight QTL 218 (human) | 1.96 | Body fat amount | percent fat | 12 | 119170322 | 126625403 | Human | n/a | region | qtl | 1000 | 2289632 | BW502_H | Body weight QTL 502 (human) | 1.5 | Body fat amount | percent fat | 12 | 120188466 | 127961399 | Human | n/a | region | qtl | 1000 | 2289630 | BW501_H | Body weight QTL 501 (human) | 2.4 | Body fat amount | percent fat | 12 | 120188466 | 127961399 | Human | n/a | region | qtl | 1000 | 2289628 | BW500_H | Body weight QTL 500 (human) | 3.8 | Body fat amount | percent fat | 12 | 120188466 | 127961399 | Human | n/a | region | qtl | 1000 | 2314793 | GLUCO112_H | Glucose level QTL 112 (human) | 2.24 | Glucose level | 12 | 120188466 | 130397814 | Human | n/a | region | qtl | |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.